Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML
Active, not recruiting · NCT05177731 · Registry updated 2024-10-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 3 | 2024-10-03 | NCT05177731 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chen Suning | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology | Suzhou | China | 6 |